Last reviewed · How we verify
licensed QIVr
QIVr is a quadrivalent influenza vaccine that stimulates the body's immune system to produce antibodies against four different influenza viruses.
QIVr is a quadrivalent influenza vaccine that stimulates the body's immune system to produce antibodies against four different influenza viruses. Used for Prevention of influenza disease caused by four different strains of the influenza virus.
At a glance
| Generic name | licensed QIVr |
|---|---|
| Sponsor | Seqirus |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
QIVr works by introducing small, harmless pieces of the influenza virus to the body, which triggers an immune response and allows the body to recognize and fight the virus in the future. This immune response is specific to the four influenza viruses included in the vaccine, providing protection against these strains of the flu.
Approved indications
- Prevention of influenza disease caused by four different strains of the influenza virus
Common side effects
- Pain, redness, swelling, or itching at the injection site
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |